Environmental, Social And Governance Report

Overview

The report presents Ascentage Pharma's 2024 group-wide ESG performance across environmental management, climate risk and workforce topics. It reports zero environmental pollution incidents and administrative penalties, and sets a target to reduce carbon emissions 50% below peak levels by 2040. Total Scope 1 and 2 GHG emissions were 7,281.64 tCO2e, while the company reported 567 employees and zero work-related fatalities.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis
Matrix

Assurance

Standard
Scope
Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services